亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Metformin Use and Age-Related Macular Degeneration in Patients Without Diabetes

医学 二甲双胍 糖尿病 四分位数 优势比 共病 内科学 黄斑变性 观察研究 逻辑回归 置信区间 眼科 内分泌学
作者
Sarthak Aggarwal,John T. Moir,Max J. Hyman,Gabriel T. Kaufmann,Andrea Flores,Seenu M. Hariprasad,Dimitra Skondra
出处
期刊:JAMA Ophthalmology [American Medical Association]
卷期号:142 (1): 53-53 被引量:36
标识
DOI:10.1001/jamaophthalmol.2023.5478
摘要

Importance: Metformin use may protect against the development of age-related macular degeneration (AMD) based on results from observational studies. However, its potential effectiveness among patients without diabetes remains unclear. Objective: To assess the association between metformin use and the development of AMD in patients without diabetes. Design, Setting, and Participants: This case-control study used data from 2006 to 2017 in the Merative MarketScan Research Database, a nationwide insurance claims database that includes between 27 and 57 million patients in the US with primary or Medicare supplemental health insurance. Cases with AMD and controls without AMD aged 55 years or older were matched 1:1 by year, age, anemia, hypertension, region, and Charlson Comorbidity Index score. Then, cases and matched controls without a diagnosis of diabetes were selected. In subgroup analyses, cases with dry AMD and their matched controls were identified to explore the association between metformin use and AMD staging in patients without diabetes. Data were analyzed between March and September 2023. Exposures: Exposure to metformin in the 2 years prior to the index date (ie, date of AMD diagnosis in cases and date of a randomly selected eye examination for controls) was assessed from the claims database and categorized into quartiles based on cumulative dose (1-270, 271-600, 601-1080, and >1080 g/2 y). Exposure to other antidiabetic medications was also noted. Main Outcomes and Measures: Odds of new-onset AMD development as assessed by multivariable conditional logistic regression after adjusting for known risk factors for AMD, including female sex, hyperlipidemia, smoking, and exposures to other antidiabetic medications. Asymptotic Cochran-Armitage tests for trend were also performed. Results: We identified 231 142 patients with any AMD (mean [SD] age, 75.1 [10.4] years; 140 172 females [60.6%]) and 232 879 matched controls without AMD (mean [SD] age, 74.9 [10.5] years; 133 670 females [57.4%]), none of whom had a diagnosis of diabetes. The sample included 144 147 cases with dry AMD that were matched to 144 530 controls. In all, 2268 (1.0%) cases and 3087 controls (1.3%) were exposed to metformin in the 2 years before their index visit. After data adjustment, exposure to any metformin was associated with reduced odds of any AMD development (adjusted odds ratio [AOR], 0.83; 95% CI, 0.74-0.87), specifically in the dosing quartiles of 1 to 270, 271 to 600, and 601 to 1080 g/2 y. Any metformin use was also associated with a reduced odds of developing dry AMD (AOR, 0.85; 95% CI, 0.79-0.92), specifically in the dosing quartiles of 1 to 270 and 271 to 600 g/2 y. Adjusted odds ratios for any AMD and dry AMD development did not differ across the dosing quartiles. Asymptotic Cochran-Armitage tests for trend revealed 2-sided P = .51 and P = .66 for the any and dry AMD samples, respectively. Conclusions and Relevance: In this case-control study of a population without a diagnosis of diabetes, metformin use was associated with reduced odds of developing AMD. This association does not appear to be dose dependent. These findings provide further impetus to study metformin's usefulness in protecting against AMD in prospective clinical trials.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
顾矜的应助被何何何采纳,获得10
23秒前
linghanlan完成签到,获得积分10
29秒前
土豆完成签到,获得积分10
32秒前
苹果梦蕊完成签到 ,获得积分10
47秒前
苗条雨完成签到,获得积分10
54秒前
59秒前
wang1231发布了新的文献求助10
1分钟前
斯文败类的应助被www采纳,获得10
1分钟前
1分钟前
辛勤的冰珍完成签到,获得积分10
1分钟前
何何何发布了新的文献求助10
1分钟前
可爱的函函的应助被于贝贝采纳,获得50
1分钟前
FashionBoy的应助被Gp1983采纳,获得30
1分钟前
感动的仇天完成签到,获得积分10
1分钟前
田様的应助被不辣的皮特采纳,获得50
1分钟前
dou完成签到 ,获得积分10
1分钟前
1分钟前
852的应助被何何何采纳,获得10
1分钟前
1分钟前
风吹麦浪的应助被听话的老太采纳,获得20
1分钟前
于贝贝完成签到,获得积分10
1分钟前
1分钟前
1分钟前
1分钟前
n01W97的应助被科研通管家采纳,获得10
1分钟前
于贝贝发布了新的文献求助50
1分钟前
传奇3的应助被美满冷安采纳,获得10
1分钟前
昏睡的映阳完成签到,获得积分10
1分钟前
2分钟前
2分钟前
美满冷安完成签到,获得积分10
2分钟前
迪恩发布了新的文献求助10
2分钟前
2分钟前
美满冷安发布了新的文献求助10
2分钟前
2分钟前
外向的冰烟完成签到,获得积分10
2分钟前
陈粒完成签到 ,获得积分10
2分钟前
榆庭完成签到,获得积分10
2分钟前
迅速的薯片完成签到,获得积分10
2分钟前
豆豆完成签到,获得积分10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190113
求助须知:如何正确求助?哪些是违规求助? 9577216
关于积分的说明 21852139
捐赠科研通 7788294
什么是DOI,文献DOI怎么找? 3436259
关于科研通互助平台的介绍 2559990
邀请新用户注册赠送积分活动 2482862